Mytos
Mytos
Revolutionary CDMO Set to Transform Stem Cell Therapies!
BIOT
🌟 Mytos launches automated CDMO for stem-cell therapies! 🔬 Tackling manufacturing challenges, aiming for 1,500 doses annually by 2026! 🚀🌍
Revolutionary Partnership: Automating Stem Cells for Parkinson’s!
BIOT
🚀 Exciting partnership! Mytos and Aspen team up to automate stem cell production for Parkinson’s therapy, enhancing efficiency and reducing costs! 🧬🏭💡
